Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tevogen Bio Holdings

1.24
+0.140012.73%
Post-market: 1.22-0.0200-1.61%19:58 EDT
Volume:1.06M
Turnover:1.34M
Market Cap:228.03M
PE:-6.05
High:1.32
Open:1.16
Low:1.16
Close:1.10
Loading ...
Jun 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 25, 2025

Major Issues Report

Form 8-K - Current report
Apr 18, 2025

Major Issues Report

Form 8-K - Current report
Apr 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 28, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 26, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 01, 2024

Correspondence

Form CORRESP - Correspondence
Jul 31, 2024

Correspondence

Form CORRESP - Correspondence
Jul 29, 2024

Correspondence

Form CORRESP - Correspondence
Jul 23, 2024

Correspondence

Form CORRESP - Correspondence
Jul 23, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]